Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1964
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1968 1
1970 2
1972 1
1974 1
1975 1
1976 1
1977 2
1981 1
1982 1
1983 3
1984 1
1989 1
1990 3
1991 1
1992 1
1994 2
1996 2
1997 1
1998 2
2000 2
2001 3
2002 1
2003 2
2004 1
2005 1
2007 1
2008 2
2009 1
2010 4
2011 2
2012 1
2013 4
2014 1
2015 4
2016 1
2017 5
2018 4
2019 4
2020 4
2021 4
2022 3
2023 2
2024 4
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Comparative pathophysiology and management of protein-losing enteropathy.
Craven MD, Washabau RJ. Craven MD, et al. J Vet Intern Med. 2019 Mar;33(2):383-402. doi: 10.1111/jvim.15406. Epub 2019 Feb 14. J Vet Intern Med. 2019. PMID: 30762910 Free PMC article. Review.
In people, PLE is usually associated with primary intestinal lymphangiectasia, suspected to arise from genetic susceptibility, or "idiopathic" lymphatic vascular obstruction. In dogs, PLE is most often a feature of inflammatory bowel disease (IBD), and less frequent …
In people, PLE is usually associated with primary intestinal lymphangiectasia, suspected to arise from genetic susceptibility, …
Clinical practice. Protein-losing enteropathy in children.
Braamskamp MJ, Dolman KM, Tabbers MM. Braamskamp MJ, et al. Eur J Pediatr. 2010 Oct;169(10):1179-85. doi: 10.1007/s00431-010-1235-2. Epub 2010 Jun 23. Eur J Pediatr. 2010. PMID: 20571826 Free PMC article. Review.
Protein-losing enteropathy (PLE) is a rare complication of a variety of intestinal disorders characterized by an excessive loss of proteins into the gastrointestinal tract due to impaired integrity of the mucosa. ...The disorders causing PLE can be divided into those due t …
Protein-losing enteropathy (PLE) is a rare complication of a variety of intestinal disorders characterized by an excessive loss of pr …
Hypomagnesemia in intestinal lymphangiectasia: a case report and review of the literature.
Feng H, Zou L, Zhai X, Zhang S, Li J. Feng H, et al. BMC Gastroenterol. 2022 May 15;22(1):246. doi: 10.1186/s12876-022-02318-6. BMC Gastroenterol. 2022. PMID: 35570283 Free PMC article.
BACKGROUND: Intestinal lymphangiectasia (IL) is a rare disease characterized by dilation of lymphatic vessels and leakage of lymphatic fluids into the intestinal lumen, causing depletion of lymphocytes, protein, lipids, fat-soluble vitamins, and electrolytes. …
BACKGROUND: Intestinal lymphangiectasia (IL) is a rare disease characterized by dilation of lymphatic vessels and leakage of l …
Magnetic Resonance Lymphangiography.
Chavhan GB, Lam CZ, Greer MC, Temple M, Amaral J, Grosse-Wortmann L. Chavhan GB, et al. Radiol Clin North Am. 2020 Jul;58(4):693-706. doi: 10.1016/j.rcl.2020.02.002. Epub 2020 May 6. Radiol Clin North Am. 2020. PMID: 32471538 Review.
It is useful in the assessment of chylothorax and chyloperitoneum. Its role in other areas such as intestinal lymphangiectasia and a variety of lymphatic anomalies is likely to increase....
It is useful in the assessment of chylothorax and chyloperitoneum. Its role in other areas such as intestinal lymphangiectasia
Intestinal Lymphangiectasia: Insights on Management and Literature Review.
Alshikho MJ, Talas JM, Noureldine SI, Zazou S, Addas A, Kurabi H, Nasser M. Alshikho MJ, et al. Am J Case Rep. 2016 Jul 21;17:512-22. doi: 10.12659/ajcr.899636. Am J Case Rep. 2016. PMID: 27440277 Free PMC article. Review.
BACKGROUND Intestinal lymphangiectasia (IL) is a rare disease characterized by a dilatation of the intestinal lymphatics and loss of lymph fluid into the gastrointestinal tract leading to hypoproteinemia, edema, lymphocytopenia, hypogammaglobinemia, and immun …
BACKGROUND Intestinal lymphangiectasia (IL) is a rare disease characterized by a dilatation of the intestinal lymphatic …
[Protein-losing enteropathy].
Amiot A. Amiot A. Rev Med Interne. 2015 Jul;36(7):467-73. doi: 10.1016/j.revmed.2014.12.001. Epub 2015 Jan 21. Rev Med Interne. 2015. PMID: 25618488 Review. French.
Most protein-losing enteropathy cases are the result of either lymphatic obstruction or a variety of gastrointestinal disorders and cardiac diseases, while primary intestinal lymphangiectasia (Waldmann's disease) is less common. Treatment of protein-losing enteropat …
Most protein-losing enteropathy cases are the result of either lymphatic obstruction or a variety of gastrointestinal disorders and cardiac …
Primary intestinal lymphangiectasia in children: A review.
Lopez RN, Day AS. Lopez RN, et al. J Paediatr Child Health. 2020 Nov;56(11):1719-1723. doi: 10.1111/jpc.14837. Epub 2020 May 28. J Paediatr Child Health. 2020. PMID: 32463559 Review.
Primary intestinal lymphangiectasia is an uncommon condition that usually presents early in childhood. ...An overview of the management of primary intestinal lymphangiectasia is outlined....
Primary intestinal lymphangiectasia is an uncommon condition that usually presents early in childhood. ...An overview of the m …
Primary intestinal lymphangiectasia in an adult patient: A case report and review of literature.
Huber R, Semmler G, Mayr A, Offner F, Datz C. Huber R, et al. World J Gastroenterol. 2020 Dec 28;26(48):7707-7718. doi: 10.3748/wjg.v26.i48.7707. Epub 2020 Dec 8. World J Gastroenterol. 2020. PMID: 33505146 Free PMC article. Review.
BACKGROUND: Primary intestinal lymphangiectasia (PIL), first described in 1961, is a rare disorder of unknown etiology resulting in protein-losing enteropathy. ...Due to suspicion of a bone marrow disease, an extensive diagnostic investigation was carried out exclud …
BACKGROUND: Primary intestinal lymphangiectasia (PIL), first described in 1961, is a rare disorder of unknown etiology resulti …
Individual approach for treatment of primary intestinal lymphangiectasia in children: single-center experience and review of the literature.
Kwon Y, Kim ES, Choe YH, Kim MJ. Kwon Y, et al. BMC Pediatr. 2021 Jan 7;21(1):21. doi: 10.1186/s12887-020-02447-5. BMC Pediatr. 2021. PMID: 33407260 Free PMC article. Review.
BACKGROUND: Intestinal lymphangiectasia is a rare disease. Thus, prospective studies are impossible, and therapy is still controversial. ...We aimed to introduce the action mechanism of each drug and treatment overview in a single-center experience and a review of t …
BACKGROUND: Intestinal lymphangiectasia is a rare disease. Thus, prospective studies are impossible, and therapy is still cont …
85 results